Browsing Patents by Subject "C07D 335/06 (20130101)"
Now showing items 1-4 of 4
-
Heteroarotinoid Compounds as Anticancer Agents
(U.S. Patent and Trademark Office, 1989-05-02)Novel heteroarotinoid compositions characterized by the formulae: ##STR1## where R is H, CH.sub.3 or C.sub.2 H.sub.5 and X is S, S O, O, NCH.sub.3, Si(CH.sub.3).sub.2, N.sup.+ (H)CH.sub.3 [Cl.sup.- ], N.sup.+ (H)CH.sub.3 ... -
Heteroarotinoids as Anticancer Agents
(U.S. Patent and Trademark Office, 1989-05-23)Novel heteroarotinoid compositions characterized by the formulae: ##STR1## where: X is S or O; OAc is the acetate group ##STR2## and R is --H, --OH, --OCH.sub.3, or --OC.sub.2 H.sub.5 and includes ##STR3## for formulae (1) ... -
Heteroarotinoids as Anticancer Agents
(U.S. Patent and Trademark Office, 1990-12-11)Novel heteroarotinoid compositions characterized by the formulae: ##STR1## where: X is S or O; OAc is the acetate group ##STR2## and R is --H, --OH, --OCH.sub.3, or --OC.sub.2 H.sub.5 and includes ##STR3## for formulae (1) ... -
Heteroarotinoids Containing Urea or Thiourea Linker
(U.S. Patent and Trademark Office, 2003-07-01)Compounds, known as heteroarotinoids, having varying abilities to inhibit growth of certain cancerous cells, induce normal cell differentiation, and induce apoptosis or death of cancerous cells, of the general formula: ...